Clinical Trial Update: Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating camrelizumab combined with apatinib, XELOX, and RFA for liver metastases from colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Hepatic Metastases

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Zhongshan Hospital Xiamen University | Conditions: Hepatic Metastasis of Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN